BridgeMD
New treatment option for Stroke,Hemiplegia
Official title Effects of Modified Constraint-Induced Movement Therapy and Mirror Therapy in Hemiplegic Stroke
ClinicalTrials.gov ID: NCT07668349
What this study is testing
- What it's testing
- The purpose of this study is to investigate and compare the effects of Modified Constraint-Induced Movement Therapy (mCIMT) and Mirror Therapy (MT) on upper extremity motor functions, activity participation, and independence in daily living activities among hemiplegic stroke patients. Participants diagnosed with stroke will be randomly assigned to intervention groups.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \ Diagnosis: Confirmed first ischemic or hemorrhagic stroke with clinical and neurological evaluation.
- Time Since Stroke: 3 to 24 months post-stroke onset.
- Hemiplegia: Significant motor deficit in the affected upper extremity.
- Motor Function Level: Presence of mild to moderate motor impairment in the affected upper extremity (FMA-UE score appropriate for the application of...
- Cognitive Status: Adequate cognitive capacity to understand and follow the study protocols (Mini-Mental State Examination score of 20 or above).
You likely can't join if
- \ Uncontrolled diabetes or other metabolic disorders.
- Progressive non-stroke neurological diseases (e.g., Parkinson's disease, multiple sclerosis).
- Terminal illness or short life expectancy.
- Severe cognitive impairment preventing comprehension or execution of the study protocols (e.g., advanced dementia).
- Severe visual impairment that prevents mirror therapy application (e.g., uncorrected visual acuity loss, neglect).
- Severe visuospatial perception disorders making it difficult to perceive or interpret the mirror image.
See the full eligibility criteria
- \ Diagnosis: Confirmed first ischemic or hemorrhagic stroke with clinical and neurological evaluation.
- Time Since Stroke: 3 to 24 months post-stroke onset.
- Hemiplegia: Significant motor deficit in the affected upper extremity.
- Motor Function Level: Presence of mild to moderate motor impairment in the affected upper extremity (FMA-UE score appropriate for the application of modified CIMT and mirror therapy).
- Cognitive Status: Adequate cognitive capacity to understand and follow the study protocols (Mini-Mental State Examination score of 20 or above).
- Visual Perception: Adequate visual perception to perform mirror therapy.
- Comorbidities: Absence of severe coexisting medical conditions that prevent participation (e.g., uncontrolled cardiovascular diseases, severe psychiatric disorders).
- Prior Treatments: No prior intensive participation in the interventions investigated in this study (modified CIMT or mirror therapy).
- Consent: Voluntary agreement to participate and signed informed consent form.
- \ Uncontrolled diabetes or other metabolic disorders.
- Progressive non-stroke neurological diseases (e.g., Parkinson's disease, multiple sclerosis).
- Terminal illness or short life expectancy.
- Severe cognitive impairment preventing comprehension or execution of the study protocols (e.g., advanced dementia).
- Severe visual impairment that prevents mirror therapy application (e.g., uncorrected visual acuity loss, neglect).
- Severe visuospatial perception disorders making it difficult to perceive or interpret the mirror image.
- Absence or minimal level of active movement in the affected upper extremity (limiting the applicability of modified CIMT).
- Significant motor deficit in the unaffected upper extremity.
- Severe and uncontrolled spasticity in the upper extremity.
The study team makes the final eligibility decision.
Where it's taking place
- Kastamonu, Merkez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kastamonu, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.